EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DT&CRO Co's enterprise value is ₩119,703 Mil.
DT&CRO Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-17,366 Mil. Therefore, DT&CRO Co's EV-to-EBITDA for today is -6.89.
The historical rank and industry rank for DT&CRO Co's EV-to-EBITDA or its related term are showing as below:
XKRX:383930'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -24.97 Med: 5.46 Max: 726.35
Current: -6.89
During the past 4 years, the highest EV-to-EBITDA of DT&CRO Co was 726.35. The lowest was -24.97. And the median was 5.46.
XKRX:383930's EV-to-EBITDA is ranked worse than 100% of 450
companies
in the Biotechnology industry
Industry Median: 9.57
vs XKRX:383930: -6.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-27), DT&CRO Co's stock price is ₩8590.00.
DT&CRO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1715.934. Therefore, DT&CRO Co's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
DT&CRO Co EV-to-EBITDA Historical Data
The historical data trend for DT&CRO Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DT&CRO Co's EV-to-EBITDA
For the Biotechnology subindustry, DT&CRO Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DT&CRO Co's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, DT&CRO Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where DT&CRO Co's EV-to-EBITDA falls into.
DT&CRO Co EV-to-EBITDA Calculation
DT&CRO Co's EV-to-EBITDA for today is calculated as:
DT&CRO Co's current Enterprise Value is ₩119,703 Mil.
DT&CRO Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-17,366 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DT&CRO Co (XKRX:383930) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
DT&CRO Co's share price for today is ₩8590.00.
DT&CRO Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1715.934.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of DT&CRO Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
DT&CRO Co Ltd conducts a series of consigned research, from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics and medical devices, to analysis, bioactivity, clinical trials, and licensing consulting. provided as a service.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:383930 has been successfully added to your 